Growth in the sports medicine market is primarily driven by factors such the increasing incidences of sports injuries, continuous influx of new products treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.

Due to the pandemic, most organized sports activities have been on hold or postponed. In March 2020, the International Olympic Committee postponed the 2020 Tokyo Olympics and Paralympic to 2021. Such developments are expected to significantly affect the growth of the sports medicine market in the coming months. 

According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID- 19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. 

Globally, the incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active participation in fitness activities (as a result of the growing focus on leading healthy lifestyles). 

For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751 

The incidence of ligament tears and fractures is high among people participating in sports. Also, the lower extremity constitutes a major portion of sports injuries, globally. With the increasing participation in sports (among children as well as adults) and subsequent growth in the incidence of sports injuries, the demand for injury management and rehabilitation is expected to increase across the globe. This is considered a positive indicator of the growth of the sports medicine market. 

The cost of these implants is a major concern for market growth in countries such as India, where only a small section of the population is under insurance coverage (according to the IRDA, in 2017, 76% of the Indian population was uninsured). With an overall average cost of more than USD 12,000 in developing countries, affording such a costly treatment is still a big challenge for most of the population. 

Similar to implants and prosthetics, regenerative medicine procedures are also expensive. For instance, the cost of a single PRP injection typically ranges from USD 500–2,000, whereas the cost of bone marrow stem cell injections ranges from USD 2,000–5,000 or more. Such therapeutic procedures often require more than one treatment, thus raising their overall cost.

Emerging countries such as India and China are home to a large patient base and are expected to offer potential growth opportunities for players operating in the sports medicine market primarily due to the rising disposable incomes in these countries (as a result of the rapid economic growth) and increasing participation in sports and physical activities. 

In the sports medicine field, there is an increasing need for trained professionals with the relevant experience and knowledge about using orthobiologics and performing specific surgeries. Sports medicine surgeons provide diagnosis and treatment for musculoskeletal injuries and related disorders that are caused during sports activities. 

Sports medicine is widely used for the prevention of sports injuries as well as for the cure, recovery, and rehabilitation of athletes. The sports medicine applications market is segmented into knee injuries, shoulder injuries, foot ankle, elbow wrist, back spine, hip groin, and other injuries. 

The major vendors in the global sports medicine market include Arthrex, Inc (US), Smith Nephew plc (UK), Stryker Corporation (US), Breg Inc. (US), DJO Global, Inc. (US), Mueller Sports, Inc. (US), Wright Medical Group N.V. (US), Medtronic (Ireland), RTI Surgical (US), Performance Health International Limited (US), KARL STORZ (Germany), and Bauerfeind AG (US), Össur (Iceland), MedShape (US), Cramer Products (US),  Biotek ( India), RôG Sports Medicine (US).